P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 212 500 KRW -2.97%
Market Cap: 2.2T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note

PharmaResearch Co Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PharmaResearch Co Ltd
Net Income (Common) Peer Comparison

Comparables:
068270
302440
H
145020
196170
A
298380

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
P
PharmaResearch Co Ltd
KOSDAQ:214450
Net Income (Common)
â‚©90.7B
CAGR 3-Years
30%
CAGR 5-Years
41%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Net Income (Common)
â‚©323.3B
CAGR 3-Years
-18%
CAGR 5-Years
6%
CAGR 10-Years
11%
SK Bioscience Co Ltd
KRX:302440
Net Income (Common)
â‚©22.3B
CAGR 3-Years
-12%
CAGR 5-Years
20%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Net Income (Common)
â‚©111.2B
CAGR 3-Years
26%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Net Income (Common)
-â‚©1.3B
CAGR 3-Years
52%
CAGR 5-Years
32%
CAGR 10-Years
N/A
A
ABL Bio Inc
KOSDAQ:298380
Net Income (Common)
-â‚©35.9B
CAGR 3-Years
12%
CAGR 5-Years
27%
CAGR 10-Years
N/A

See Also

What is PharmaResearch Co Ltd's Net Income (Common)?
Net Income (Common)
90.7B KRW

Based on the financial report for Jun 30, 2024, PharmaResearch Co Ltd's Net Income (Common) amounts to 90.7B KRW.

What is PharmaResearch Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
41%

Over the last year, the Net Income (Common) growth was 63%. The average annual Net Income (Common) growth rates for PharmaResearch Co Ltd have been 30% over the past three years , 41% over the past five years .

Back to Top